Chemoinformaics analysis of 5,7-DIHYDROXYCHROMONE
| Molecular Weight | 178.143 | nRot | 0 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 12 |
| Exact Molecular Weight | 178.027 | nRing | 2 |
| Solubility: LogS | -2.65 | nHRing | 1 |
| Solubility: LogP | 1.315 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 22.2388 |
| nHD | 2 | BPOL | 8.62324 |
| QED | 0.635 |
| Synth | 2.484 |
| Natural Product Likeliness | 1.705 |
| NR-PPAR-gamma | 0.644 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.69 |
| HIA | 0.012 |
| CACO-2 | -4.776 |
| MDCK | 0.00000941 |
| BBB | 0.037 |
| PPB | 0.872031 |
| VDSS | 0.74 |
| FU | 0.241064 |
| CYP1A2-inh | 0.968 |
| CYP1A2-sub | 0.495 |
| CYP2c19-inh | 0.166 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.31 |
| CYP2c9-sub | 0.923 |
| CYP2d6-inh | 0.614 |
| CYP2d6-sub | 0.577 |
| CYP3a4-inh | 0.472 |
| CYP3a4-sub | 0.113 |
| CL | 10.349 |
| T12 | 0.905 |
| hERG | 0.055 |
| Ames | 0.279 |
| ROA | 0.149 |
| SkinSen | 0.914 |
| Carcinogencity | 0.594 |
| EI | 0.982 |
| Respiratory | 0.489 |
| NR-Aromatase | 0.069 |
| Antiviral | No |
| Prediction | 0.767815 |